These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 37842592)
41. High expression of RNF169 is associated with poor prognosis in pancreatic adenocarcinoma by regulating tumour immune infiltration. Wang J; Chen H; Deng Q; Chen Y; Wang Z; Yan Z; Wang Y; Tang H; Liang H; Jiang Y Front Genet; 2022; 13():1022626. PubMed ID: 36685833 [No Abstract] [Full Text] [Related]
42. Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma. Li L; Xiao Z; He P; Zou W; Deng Z; Zhang G; Liu R BMC Gastroenterol; 2022 Nov; 22(1):454. PubMed ID: 36371178 [TBL] [Abstract][Full Text] [Related]
43. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma. Ma C; Kang W; Yu L; Yang Z; Ding T Front Oncol; 2020; 10():590006. PubMed ID: 33363020 [TBL] [Abstract][Full Text] [Related]
44. High Matrix Metalloproteinase 28 Expression is Associated with Poor Prognosis in Pancreatic Adenocarcinoma. Liu N; Zhong L; Ni G; Lin J; Xie L; Li T; Dan H; Chen Q Onco Targets Ther; 2021; 14():4391-4406. PubMed ID: 34408436 [TBL] [Abstract][Full Text] [Related]
45. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma. Huang J; Chen Z; Ding C; Lin S; Wan D; Ren K Front Oncol; 2021; 11():711402. PubMed ID: 34497764 [TBL] [Abstract][Full Text] [Related]
46. Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making. Zhu J; Shi Y; Lan S; Wang J; Jiang F; Tang C; Cai Y; Pan Z; Jian H; Fang H; Zhang Y; Zhong F Apoptosis; 2023 Jun; 28(5-6):769-782. PubMed ID: 36882663 [TBL] [Abstract][Full Text] [Related]
47. Development and validation of a novel 3-gene prognostic model for pancreatic adenocarcinoma based on ferroptosis-related genes. Yang J; Wei X; Hu F; Dong W; Sun L Cancer Cell Int; 2022 Jan; 22(1):21. PubMed ID: 35033072 [TBL] [Abstract][Full Text] [Related]
48. Wu Q; Li J; Wang P; Peng Q; Kang Z; Deng Y; Li J; Yan D; Ge F; Chen Y Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36981005 [TBL] [Abstract][Full Text] [Related]
49. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
50. The diagnostic significance of the ZNF gene family in pancreatic cancer: a bioinformatics and experimental study. Zhu L; Tu D; Li R; Li L; Zhang W; Jin W; Li T; Zhu H Front Genet; 2023; 14():1089023. PubMed ID: 37396042 [No Abstract] [Full Text] [Related]
51. High RAS-related protein Rab-7a (RAB7A) expression is a poor prognostic factor in pancreatic adenocarcinoma. Liu Q; Bai Y; Shi X; Guo D; Wang Y; Wang Y; Guo WZ; Zhang S Sci Rep; 2022 Oct; 12(1):17492. PubMed ID: 36261459 [TBL] [Abstract][Full Text] [Related]
52. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma. Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576 [TBL] [Abstract][Full Text] [Related]
53. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer. Guo Y; Wang R; Li J; Song Y; Min J; Zhao T; Hua L; Shi J; Zhang C; Ma P; Yang C; Zhu L; Gan D; Li S; Liu X; Su H Front Immunol; 2021; 12():769425. PubMed ID: 34804059 [TBL] [Abstract][Full Text] [Related]
54. Prognostic Value of E2F Transcription Factor Expression in Pancreatic Adenocarcinoma. Luo L; Zhang G; Wu T; Wu G Med Sci Monit; 2021 Nov; 27():e933443. PubMed ID: 34799547 [TBL] [Abstract][Full Text] [Related]
55. Comprehensive Analysis of 5-Methylcytosine (m Wang R; Guo Y; Ma P; Song Y; Min J; Zhao T; Hua L; Zhang C; Yang C; Shi J; Zhu L; Gan D; Li S; Li J; Su H Front Oncol; 2022; 12():851766. PubMed ID: 35433474 [TBL] [Abstract][Full Text] [Related]
56. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types. Guo B; Wang Y; Liu W; Zhang S Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654 [TBL] [Abstract][Full Text] [Related]
57. Exploring the significance of novel immune-related gene signatures in the prognosis and immune features of pancreatic adenocarcinoma. Chen B; Hu C; Jiang L; Xiang Z; Zuo Z; Lin Y; Liu C Int Immunopharmacol; 2021 Mar; 92():107359. PubMed ID: 33465729 [TBL] [Abstract][Full Text] [Related]
58. An immune-related gene prognostic risk index for pancreatic adenocarcinoma. Su Y; Qi R; Li L; Wang X; Li S; Zhao X; Hou R; Ma W; Liu D; Zheng J; Shi M Front Immunol; 2022; 13():945878. PubMed ID: 35958614 [TBL] [Abstract][Full Text] [Related]
59. LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression. Li T; Zhao H; Zhou H; Geng T PLoS One; 2021; 16(3):e0247817. PubMed ID: 33661995 [TBL] [Abstract][Full Text] [Related]
60. Identification of G-protein signaling modulator 2 as a diagnostic and prognostic biomarker of pancreatic adenocarcinoma: an exploration of its regulatory mechanisms. Zhou X; Dang S; Jiang H; Gu M J Gastrointest Oncol; 2021 Jun; 12(3):1164-1179. PubMed ID: 34295565 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]